CytoMed Therapeutics (GDTC) Market Capitalization (2023 - 2025)

CytoMed Therapeutics has disclosed Market Capitalization across 3 years of filings, most recently posting $15.9 million for Q4 2025.

• In Q4 2025, Market Capitalization fell 59.6% year-over-year to $15.9 million; the TTM figure through Dec 2025 stood at $15.9 million (down 59.6% YoY), while the FY2025 annual figure was $15.9 million, down 59.6% from the prior year.
• Market Capitalization came in at $15.9 million for Q4 2025 at CytoMed Therapeutics, down from $26.0 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $56.5 million in Q4 2023 to a low of $15.9 million in Q4 2025.
• Average Market Capitalization over 3 years is $31.0 million, with a median of $25.1 million recorded in 2023.
• The largest YoY upside for Market Capitalization was 8.17% in 2025 against a maximum downside of 59.6% in 2025.
• Over 3 years, Market Capitalization stood at $56.5 million in 2023, then tumbled by 30.61% to $39.2 million in 2024, then plunged by 59.6% to $15.9 million in 2025.
• Per Business Quant data, the three most recent Market Capitalization figures were $15.9 million in Q4 2025, $26.0 million in Q2 2025, and $39.2 million in Q4 2024.